Putnam Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-101,368
| Closed | -$15.3M | – | 1237 |
|
|
2022
Q3 | $15.3M | Sell |
101,368
-8,095
| -7% | -$1.22M | 0.03% | 223 |
|
|
2022
Q2 | $16M | Buy |
109,463
+22,240
| +25% | +$3.24M | 0.03% | 229 |
|
|
2022
Q1 | $10.3M | Buy |
87,223
+1,541
| +2% | +$183K | 0.02% | 335 |
|
|
2021
Q4 | $11.8M | Buy |
85,682
+2,933
| +4% | +$404K | 0.02% | 334 |
|
|
2021
Q3 | $11.5M | Sell |
82,749
-21
| -0% | -$2.92K | 0.02% | 330 |
|
|
2021
Q2 | $8.04M | Buy |
82,770
+2,500
| +3% | +$243K | 0.01% | 418 |
|
|
2021
Q1 | $5.49M | Hold |
80,270
| – | – | 0.01% | 478 |
|
|
2020
Q4 | $6.88M | Sell |
80,270
-871
| -1% | -$74.7K | 0.01% | 439 |
|
|
2020
Q3 | $5.28M | Sell |
81,141
-90
| -0.1% | -$5.85K | 0.01% | 471 |
|
|
2020
Q2 | $5.94M | Buy |
81,231
+16,164
| +25% | +$1.18M | 0.01% | 434 |
|
|
2020
Q1 | $2.22M | Sell |
65,067
-370
| -0.6% | -$12.6K | 0.01% | 591 |
|
|
2019
Q4 | $3.56M | Buy |
+65,437
| New | +$3.56M | 0.01% | 596 |
|